Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sandostatin LAR in chronic symptomatic sarcoidosis
NL-OMON40194Phase 2Active, not recruiting
- Sponsor
- Erasmus MC
- Start
- Jul 2014
- Modality
- Peptides
- Countries
- 1
01
Overview
Phase 2 trial of octreotide, sponsored by Erasmus MC. Started Jul 2014; status: active, not recruiting.
02
Drugs
octreotide
Beyond the preview
Go deeper on NL-OMON40194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON40194.